Author

Irwin Sandhu

Observed names: I Sandhu, I. Sandhu, Irwindeed Sandhu

Institutions: University of Alberta, Cross Cancer Institute

Observed institutions: University of British Columbia, University of Alberta, Cross Cancer Institute

OpenAlex ID: A5086160876

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis

2007 · Sarah S. Fung, Kortney L. Hillier, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 51

P34 | Cevostamab Plus Pomalidomide and Dexamethasone in Patients With Relapsed/refractory Multiple Myeloma: Biomarker Analyses From Camma 1 Arm B

2026 · R. Popat, S. Harrison, et al. · Haematologica · 1

Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study

2025 · Adrian Wong, Victor H. Jimenez-Zepeda, et al. · Blood Cancer Journal · 1

Evaluating the cardiovascular risk profiles of multiple myeloma patients before and 1 year after autologous stem cell transplant

2026 · A De Boer, M Ebeid, et al. · European Heart Journal Supplements

B09 | Daratumumab Monotherapy Versus Active Monitoring in Patients With High-risk Smoldering Multiple Myeloma: "aquila" Outcomes Based on Mayo 2018/imwg 2020 Risk Stratification, Imwg 2020 Plus Cytogenetic Criteria, and Age

2026 · F. Schjesvold, P.M. Voorhees, et al. · Haematologica

Abstract 2597: Baseline cfDNA fragmentomics identifies multiple myeloma patients at risk of early progression

2026 · Dor David Abelman, Jenna Eagles, et al. · Cancer Research

P-162 Cell-free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma

2024 · Dor Abelman, Jenna Eagles, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 7

Citation count: 53

H-index: 1

I10-index: 1